Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 20, 2021 07:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma appoints Dr. Christian Schetter as Chief Scientific Officer, strengthening scientific focus

LAUPHEIM, Germany and MILFORD, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
August 12, 2021 08:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma breaks ground at new U.S. production site in greater Boston

New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
March 31, 2021 04:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation

LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
March 22, 2021 05:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma and Leukocare extend service offering with joint U.S. site

Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clientsClient-focused approach and integration of best-in-class...
February 11, 2021 04:10 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK

New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansionCenter of Excellence to address the gap in capacity...
February 11, 2021 04:00 ET | Source: Rentschler Biopharma SE; The Cell and Gene Therapy Catapult

Rentschler Biopharma to build new cell and gene therapy capabilities in the UK

Rentschler Biopharma will establish their ATMP development and manufacturing capabilities at the Cell and Gene Therapy Catapult facility in StevenageAgreement confirms UK’s global attractiveness for...
May 27, 2020 09:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma Extends Collaboration with Genmab to U.S. facility

Innovative agreement provides flexible model to address Genmab’s development and manufacturing needs as programs advance in developmentRentschler Biopharma’s U.S. site expansion progressing on track...
November 18, 2019 10:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma Appoints New Executives to Join U.S. Team

New heads of Process Sciences and Human Resources departmentsBoth positions newly created as site expands and ramps up business LAUPHEIM, Germany and MILFORD, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE)...
October 10, 2019 10:00 ET | Source: Rentschler Biopharma SE

Rentschler Biopharma Announces Appointment of Karen Savage to Milford Area Chamber of Commerce Board of Directors

LAUPHEIM, Germany and MILFORD, Mass., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals,...